United States

Welcome to **ENDO** - the place where leading experts, researchers, and the most respected clinicians in the field come together to share the latest findings in hormone science and discuss breakthroughs in clinical care.

**Endocrine Society** is a global community of physicians and scientists dedicated to accelerating scientific breakthroughs and improving patient health and well being.
<br><br>
For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. **[Read about our history](https://www.endocrine.org/our-community/advancing-endocrinology-and-public-health/history)** and how we continue to serve the endocrine community.

ENDO 2020

ENDO is the place where leading experts, researchers, and the most respected clinicians in the field come together to share the latest findings in hormone science and discuss breakthroughs in clinical care.

ENDO 2021

If we knew then what we know now would we have approached the development of Endocrine therapies differently?

keynote

Life Cycle of a Patient with Obesity Case Scenarios Featuring a Standardized Patient On: Medical Therapy

Life Cycle of a Patient with Obesity Case Scenarios Featuring a Standardized Patient On: Surgery

Regulation of Mouse Uterine Contractility by Regulator of G-Protein Signalling 2

Kisspeptin as a Biomarker for Pregnancy Complications

Ovarian Follicle Survival Is Determined by Follicle-Stimulating Hormone Receptor (FSHR) and Estrogen Receptor (GPER) Heteromers

The Expression of the Homeodomain Transcription Factor SIX3 within Kisspeptin Neurons Is Necessary for Reproduction in Mice

Circadian Regulation of Chromatin State Mediates Pancreatic Islet Incretin Response

Hepatocyte Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Offsets the Anti-Steatogenic Effects of Thiazolidinediones in Obese Male Mice

The Transcriptional Coactivation Function of EHMT2 Restricts Chronic Glucocorticoid Exposure Induced Insulin Resistance

Epinephrine Is Essential for Normal Renal Glucose Reabsorption via the Glucose Transporter GLUT2

symposium

technical paper

https://d3smihljt9218e.cloudfront.net/transcript/30914/subtitle/2092dad4a1589aa85b2918aceb25c3e2.vtt

English (automatic)

Premium content

If we knew then what we know now would we have approached the development of Endocrine therapies differently?

Next from ENDO 2020

Life Cycle of a Patient with Obesity Case Scenarios Featuring a Standardized Patient On: Medical Therapy

Similar lectures

Anti-Obesity Pharmacotherapy for the Treatment of Adolescents with Obesity: Where Are We Now? Where Are We Going